CATX

Perspective Therapeutics to Provide Business Highlights and Report First Quarter 2025 Financial Results

04/17 07:00 am

Pharma-Biotech Market Development Analysis Report 2025: Growth Opportunities Shaped by a Convergence of Scientific Innovation, Regulatory Evolution, and Market Pressures

04/01 08:00 am

Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

03/17 07:00 am

Perspective Therapeutics to Provide Business Highlights and Report Full Year 2024 Financial Results

02/21 08:00 am

Perspective Therapeutics to Participate in Upcoming February Investor Conferences

02/05 08:00 am

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium

01/24 08:00 am

Targeted Alpha Therapy Market, Drugs Approval, Proprietary Technologies & Clinical Trials: 20+ Drugs of Targeted Alpha Therapy In Clinical Trials

12/16 11:53 am

Targeted Alpha Therapy Market 2028

12/12 01:55 pm

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine

10/23 07:00 am

Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day

10/07 07:00 am

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet - Zacks Investment Research

07/16 09:01 am

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

06/12 07:00 am

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

06/10 04:10 pm

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

05/24 08:01 am

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

05/20 07:00 am

Perspective Therapeutics to Participate at Upcoming May Investor Conferences

05/03 07:00 am

Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results

05/02 07:00 am

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

04/08 08:00 am

Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?

03/28 01:49 pm

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

03/28 07:30 am

Perspective Therapeutics Announces $87.4 Million Private Placement

03/04 10:45 am

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

02/13 11:00 am

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline

02/08 11:00 am

Expensify And 3 Other Stocks Under $3 Insiders Are Buying

02/02 08:09 am

Expensify And 2 Other Stocks Under $2 Insiders Are Buying

01/31 07:30 am

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

01/30 10:40 am

Perspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying

01/29 09:53 am

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

01/22 05:05 pm

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

01/18 08:00 am

Perspective Therapeutics Announces Proposed Public Offering

01/17 05:05 pm

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

01/17 09:00 am

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

01/09 09:00 am

GeoVax Labs And 2 Other Stocks Under $2 Insiders Are Buying

12/27 09:55 am

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

12/19 09:29 am

Perspective Therapeutics Reports Third Quarter Fiscal 2023 Results and Recent Business Highlights

11/14 05:25 pm

Perspective Therapeutics Completes Recruitment for First Patient Cohort in Phase 1/2a Dose Escalation Trial of VMT01 in Malignant Melanoma

10/16 08:00 am

Perspective Therapeutics’ Cesium-131 Featured at the American Society for Radiation Oncology’s Annual Conference

10/05 04:05 pm

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

09/19 12:49 pm

Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

09/19 07:59 am

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

09/18 01:25 pm

Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket

09/18 08:10 am

Perspective Therapeutics to Present at the World Molecular Imaging Congress 2023

08/30 08:17 am

Perspective Therapeutics (CATX) Reports Q2 Loss, Lags Revenue Estimates

08/11 09:15 am

Perspective Therapeutics Announces First Patient Dosed in Phase 1/2a Dose Escalation Trial of VMT01 of its Targeted Alpha-Particle Therapy (TAT), for Treatment of MC1R-positive Metastatic Melanoma

08/11 08:05 am

Perspective Therapeutics Reports Second Quarter Fiscal 2023 Results and Recent Business Highlights

08/11 08:00 am

Perspective Therapeutics and GT Medical Technologies Collaborate to Expand Access to Unique Cesium-131 Based Brain Cancer Treatment

08/09 08:05 am

Perspective Therapeutics Initiates Phase 1/2a Clinical Trials for Two Targeted Alpha Therapy Oncology Product Candidates

06/21 08:00 am

Perspective Therapeutics’ Cesium-131 to be Featured in Presentations at the 2023 American Brachytherapy Society’s Annual Meeting

06/16 08:00 am

Perspective Therapeutics to Present at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS)

05/24 08:10 am

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

05/16 01:13 pm